Status:
COMPLETED
MISC-CBO in Children Affected by HIV/AIDS
Lead Sponsor:
University of Houston
Collaborating Sponsors:
University of the Free State
Michigan State University
Conditions:
HIV Affected Children (Single and/or Double Orphans)
Eligibility:
All Genders
7-11 years
Phase:
NA
Brief Summary
Currently, 12 million children in Sub-Saharan Africa and 1.9 million children in South Africa (SA) are orphaned by HIV/AIDS. Research addressing what can be done to support these children has been lim...
Detailed Description
Currently, 12 million children in Sub-Saharan Africa and 1.9 million children in South Africa (SA) are orphaned by HIV/AIDS1. Research addressing what can be done to support these children has been li...
Eligibility Criteria
Inclusion
- orphaned (UNICEF criterion of one or both parents deceased from AIDS)
- HIV/AIDS affected child as determined by verbal autopsy measure to determine cause of death of biological parent(s)
- 7-11 year old
- resident in the CBO catchment area
- principle home caregiver of the child should be able to participate in baseline and follow-up assessments
Exclusion
- medical history of serious birth complications
- severe malnutrition, bacterial meningitis
- encephalitis
- cerebral malaria
- known brain injury or disorder requiring hospitalization
- continued evidence of seizure or other neurological disability
- HIV infection
Key Trial Info
Start Date :
February 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2018
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04359043
Start Date
February 1 2017
End Date
March 30 2018
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Community Development Support Center, UFS
Bloemfontein, Free State, South Africa, 9301